124 related articles for article (PubMed ID: 27560704)
21. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
[TBL] [Abstract][Full Text] [Related]
22. Effects of Acute Caffeine Intake on Insulin-Like Growth Factor-1 Responses to Total Sleep Deprivation: Interactions with COMT Polymorphism - A Randomized, Crossover Study.
Drogou C; Sauvet F; Erblang M; Leger D; Thomas C; Chennaoui M; Gomez-Merino D;
Lifestyle Genom; 2023; 16(1):113-123. PubMed ID: 37279709
[TBL] [Abstract][Full Text] [Related]
23. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
24. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
26. Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity.
Pedraz M; Martín-Velasco AI; García-Marchena N; Araos P; Serrano A; Romero-Sanchiz P; Suárez J; Castilla-Ortega E; Barrios V; Campos-Cloute R; Ruiz JJ; Torrens M; Chowen JA; Argente J; de la Torre R; Santín LJ; Villanúa MÁ; Rodríguez de Fonseca F; Pavón FJ
PLoS One; 2015; 10(3):e0118610. PubMed ID: 25734326
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.
Paolisso G; Ammendola S; Del Buono A; Gambardella A; Riondino M; Tagliamonte MR; Rizzo MR; Carella C; Varricchio M
J Clin Endocrinol Metab; 1997 Jul; 82(7):2204-9. PubMed ID: 9215295
[TBL] [Abstract][Full Text] [Related]
28. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors.
de Groof F; Joosten KF; Janssen JA; de Kleijn ED; Hazelzet JA; Hop WC; Uitterlinden P; van Doorn J; Hokken-Koelega AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3118-24. PubMed ID: 12107211
[TBL] [Abstract][Full Text] [Related]
29. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
[TBL] [Abstract][Full Text] [Related]
30. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback.
Chapman IM; Hartman ML; Pezzoli SS; Harrell FE; Hintz RL; Alberti KG; Thorner MO
J Clin Endocrinol Metab; 1997 Sep; 82(9):2996-3004. PubMed ID: 9284733
[TBL] [Abstract][Full Text] [Related]
31. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
[TBL] [Abstract][Full Text] [Related]
32. Sleeping during the day: effects on the 24-h patterns of IGF-binding protein 1, insulin, glucose, cortisol, and growth hormone.
Rehman JU; Brismar K; Holmbäck U; Akerstedt T; Axelsson J
Eur J Endocrinol; 2010 Sep; 163(3):383-90. PubMed ID: 20587581
[TBL] [Abstract][Full Text] [Related]
33. Two nights of recovery sleep restores the dynamic lipemic response, but not the reduction of insulin sensitivity, induced by five nights of sleep restriction.
Ness KM; Strayer SM; Nahmod NG; Chang AM; Buxton OM; Shearer GC
Am J Physiol Regul Integr Comp Physiol; 2019 Jun; 316(6):R697-R703. PubMed ID: 30892916
[TBL] [Abstract][Full Text] [Related]
34. Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders.
García-Marchena N; Silva-Peña D; Martín-Velasco AI; Villanúa MÁ; Araos P; Pedraz M; Maza-Quiroga R; Romero-Sanchiz P; Rubio G; Castilla-Ortega E; Suárez J; Rodríguez de Fonseca F; Serrano A; Pavón FJ
PLoS One; 2017; 12(11):e0187634. PubMed ID: 29108028
[TBL] [Abstract][Full Text] [Related]
35. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.
Ong K; Kratzsch J; Kiess W; Costello M; Scott C; Dunger D
J Clin Endocrinol Metab; 2000 Nov; 85(11):4266-9. PubMed ID: 11095465
[TBL] [Abstract][Full Text] [Related]
36. Negative energy balance plays a major role in the IGF-I response to exercise training.
Nemet D; Connolly PH; Pontello-Pescatello AM; Rose-Gottron C; Larson JK; Galassetti P; Cooper DM
J Appl Physiol (1985); 2004 Jan; 96(1):276-82. PubMed ID: 12949013
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
38. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin.
Lang CH; Pollard V; Fan J; Traber LD; Traber DL; Frost RA; Gelato MC; Prough DS
Am J Physiol; 1997 Jul; 273(1 Pt 2):R371-8. PubMed ID: 9249574
[TBL] [Abstract][Full Text] [Related]
39. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
40. Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men.
Veldhuis JD; Bidlingmaier M; Anderson SM; Wu Z; Strasburger CJ
J Clin Endocrinol Metab; 2001 Jul; 86(7):3304-10. PubMed ID: 11443205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
